, page-35. Kazia announces Clinical Data at ESMO 2023 from EVT801 Study In one embodiment, the treatment provides for an inhibition of increase in prostate specific antigen (PSA) score, or for inhibition of tumour growth. 421 for the Glioblast milestone (initial announcement 31/3/21) will be out of. Australia's largest stock trading and investment forum Australia's #1 stock forumFind the latest Kazia Therapeutics Limited (KZIA) stock quote, history, news and other vital information to help you with your stock trading and investing. 0 Great analysis. ASX - General. Created with Sketch. . . We constantly hear how the market does not have the ability to value pre clinical companies etc Newbies DYOR regarding why KZA's share price is at current. Regards. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. ASX - Day Trading Share Prices & Charts for KAZIA THERAPEUTICS LIMITED. ASX - By Stock. , page-2. 0¢ KAZIA THERAPEUTICS LIMITED - Discussion. Created with Sketch. Created with Sketch. KZA PRICE PERFORMANCESince November 2021 the SP has dropped from $1. The price action today on KZA has opened up a great buying opportunity in my. 3 Easy money to be made. 81M. 62 as at the end June 2022This is a reduction of 60%This in despite of the. SYDNEY, Aug. Share Sounds like JG's options, maybe it was the rejection of his 0. Also, Chimeric Therapeutics (ASX : CHM) are developing CAR-T cell therapy for GBM, where the cells are injected directly into the brain. KZA is so volatile and there is a lot of trading going on (heightened volume lately). 52, $0. But don't blame other factors, the CEO must move forward with more aggressive promotion, of the company. Forums. Created with Sketch. Created with Sketch. Join the HotCopper ASX share market forum today for free. Share KAZIA’S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN PRECLINICAL MODELS OF MELANOMA Sydney, 27 October 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of new data from an ongoing research collaboration with the Huntsman Cancer Institute at the Harvett, how much do you think a partner would be willing to pay for Cantrixil? A search will show that the Cantrixil Phase 1 abstract has been accepted. Created with Sketch. Market Cap $17. Created with Sketch. - KZA have a market cap of only $25m - Considering it's prime drug candidate is linked with Roche - Genentech a $240b company - no buyers or interest at all - P hopper selling out atone of the most significant time in company's history - before resultsshare. ASX - By Stock. June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) : US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN. Latest Posts. Now idelalisib which was the first to be FDA approved had the following toxicity issues "A phase II trial in patients with chronic lymphocytic leukemia found that idelalisib used as upfront therapy caused an early,. 3. Created with Sketch. KZA Price at posting: 8. Lets assume a 30% net profit on reduced sales of $1B for an annual net profit of $300M. ASX - By Stock. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. Created with Sketch. In one. Like people are not interested in us,Kazia releases preliminary Cantrixil Phase I data, page-2. After market transaction 420,000 @ $0. Application for quotation of securities - KZA. The sequential phase3 is expected to be complete in approximately 2 to 3 years. This has been going on for months. They are in phase 1 trial now and plan to undertake a pivotal phase 2 trial after which registration may be possible if results are good. Forums. Forums. Commodities. Share Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Created with Sketch. ASX - By Stock. Forums. Kazia GDC-0084 SNO poster, page-4. Market . They needed also to recruit the same number of patients in the TZM arm of the trial. ASX - By Stock. Created with Sketch. MX1 fundamental analysis. ASX - Day TradingCreated with Sketch. The Company primarily explores for. , page-3. 5 Upvote. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. ASX - By Stock. Maybe this post header could be retained for information relating to relevant info. . - KZA have a market cap of only $25m - Considering it's prime drug candidate is linked with Roche - Genentech a $240b company - no buyers or interest at all - P hopper selling out atone of the most significant time in company's history - before results share. , page-8. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. ASX - Day TradingCreated with Sketch. Created with Sketch. . ASX - General. 03/11/23. ASX - Short Term Trading. ASX - Day TradingGreat news - new studies continue to open! 18+100 new patients to start with. Other companies talk like this - and maybe finally KZA realise what it takes, in this hopelessly undervalued stock. ASX - Day TradingKinda a noob investor here, but just logged into my Link account after hearing the KZA news. 5B pa. Proposed issue of securities - KZA. be great if the FDA does consent to early marketing. Latest Posts. Commodities. International Markets. Looking for a better opportunity | Learn more about Kisa Zehra's work experience, education, connections & more by visiting their profile on LinkedInCurrent Hospital Appointment: Attending Radiation Oncologist, Kingston Health Sciences Centre; Division Head, Radiation Oncology; Other Current Appointments:1. Created with Sketch. Created with Sketch. 4 billion company - called ONE DAY - who is approaching the FDA for marketing approval, following a Phase 2 study in a type of childrens brain cancer, with BRAF mutations. In one embodiment, the treatment provides for an inhibition of increase in prostate specific antigen (PSA) score, or for inhibition of tumour growth. Created with Sketch. This is for informational purposes only. NVGN still waiting to rocket or at least play catch up. - for cd ctc socal apch at 800-448-3724. 89 million shares. . Created with Sketch. But on the surface not a very pleasing read!! Expand. That is why KZA spent the extra time and effort on pushing for a higher MTD and safety factors of GDC-0084. ASX - By Stock. Advertise on HotCopper. Latest Posts. ASX - Short Term Trading. Forums. Nothing to do with Edison Reports, or Capital Raisings,. Forex. ASX - Day Trading. ASX - Day TradingAbsract- AACR - The dual P13KmTOR-pathway inhibitor-GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases. ASX - By Stock. Forums. when from here will we double our S. That's equiv. Currently unlisted public company. Feb 23 (Reuters) - Kazia Therapeutics Ltd (KZA) : LOSS FOR HALF-YEAR ATTRIBUTABLE A$13. ASX - By Stock. 10:38. Valuation. . ASX - By Stock. . KZA is so volatile and there is a lot of trading going on (heightened volume lately). , page-2. Charts. ASX - By Stock. 1 Upvote. Just for some fun. 84% 5. ASX - By Stock. Bring on Wednesday trading in Aus! CnS, page-5. Created with Sketch. Kazia Therapeutics Limited (KZIA) NasdaqCM - NasdaqCM Real Time Price. KZA PRICE PERFORMANCESince November 2021 the SP has dropped from $1. 8m, page-2. . Who knows which way it will go over coming weeks. . 465. Join the HotCopper ASX share market forum today for free. ASX - By Stock. Regards. Forums. British Medical Journal unlikely. The estimate is that there could be sales of up to $1. Thus the model is working so far. Kazia joins GBM Agile, page-3. 0¢ Change 0. . Click for more information. Join the HotCopper ASX share market forum today for free. 0. ASX - Day TradingCreated with Sketch. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. Join to connectWhat would happen to the share price if KZA went it alone in marketing pAX. , page-9. Created with Sketch. ASX - By Stock. Market . I have to open another international trading account with commsec now because I also hold KZA in my own name so I will find out how complicated it is for individuals. Created with Sketch. Who knows which way it will go over coming weeks. 000(0. . . Micro-X Limited designs, develops, manufactures, and commercializes medical and security imaging products using cold cathode X-ray technology for the healthcare and security markets in Australia. Folks say we are pioneers of craft ice cream in Victoria. Latest Posts. , page-7. What would happen to the share price if KZA went it alone in marketing pAX. Share Anyone else get the sense the Nasdaq move is engineered around news from either ESMO (21/10/23) or more likely, SNO on the 16/11/23 ? In the meantime we are looking oversold. I haven't been able to find the details on the pre-defined criteria for moving into Stage 2. . Market . . ASX - By Stock. KZA. This is what it takes, in the small cap biotech sector. ASX - By Stock. $0. having said that they seem very casual about anything to do with KZA- example a buy order of mine sat there for 15-20 minutes despite sellers for my volume being right on front of my nose. Share" Kazia CEO, Dr James Garner, commented, “China is one of the world’s largest pharmaceutical markets, with specific requirements and opportunities for innovative Potential exhaustion levels for the current pullback are $0. Market . ASX - Day TradingCreated with Sketch. This is a bit advanced, but I came across this video which discusses and shows how certain mutations in epigenetic machinery (histone tails) can lead to. International Markets. Sure to be part of any submission to the FDA by Kazia for (hopefully) early GBM marketing approval from the. 44 - just writing that hurts for every $1,000 dollars I should. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. The KZA CEO said only in recent days, GDC 0084 works in other cancers outside of the Brain, for PI3k mutated cancers. View the site here National Workshops More Info Webinars Watch Now Products Purchase. Last updated 15. Created with Sketch. Join the HotCopper ASX share market forum today for free. It's all about the long game. After market transaction 420,000 @ $0. Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forumManagement needs to clarify what the future is for KZA and where they see it heading out n the next 12 months. Click for more information. I read that Final Data from P1 study was due at ESMO 19-21 September 2020 (Hidden Gems Webinar). Lindsay Elizabeth Buziak (November 2, 1983 – February 2, 2008) was a Canadian real estate agent who was murdered on February 2, 2008, during a property viewing in. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. Created with Sketch. Including Brown. 52 would see the support line of the uptrend remain. , page-3. Last updated 15. 99M. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. In one embodiment the treatment provides for a reduction in PSA score, preferably a 50%, 60%, 70%, 80%, 90% or 100% reduction in PSA score. Created with Sketch. KAZIA TO PRESENT AT LD MICRO "We look forward to updating the attendees on our progress, and on the rich slate of news flow anticipated for the second. ASX - By Stock. Kazia share purchase planBack to good old red, the tried and tested color that KZA investors love most. Forums. 00%) Mkt cap ! $18. Latest Posts. Forums. You can only laugh. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. Created with Sketch. Created with Sketch. 1 Upvote. So who knows what they're up too. Initiation Report: MyFiziq (ASX: MYQ) generating million dollar revenues. Charts. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. ASX - Short Term Trading. Share Yes Rinnekin - the announcement makes reference to use of the 15% placement facility - when in fact 15 m of the total new shares came from. Commodities. Latest Posts. Created with Sketch. 5. 1 Upvote. Forums. . Created with Sketch. KZA. 10/05/19. 17M. Looks like HC went and merged the NRT thread with KZA anyway. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has been awarded a Rare Paediatric Disease Designation (RPDD) by the US Food and Drug Administration (FDA) for the use of paxalisib in the treatment of atypical rhabdoid/teratoid tumours (AT/RT), a rare and highly aggressive childhood brain cancer. Market . Created with Sketch. Advertise on HotCopper. Created with Sketch. So miles behind, but may. Interestingly John Friend’s last few appointments have a 1. ASX - Day TradingCreated with Sketch. . Click for more information. ASX - By Stock. , page-33. . ASX - By Stock. 52, $0. Join the HotCopper ASX share market forum today for free. . A reversal at $0. What I see is control to budget, timeline and quality. 00%) Mkt cap ! $18. Lets assume a 30% net profit on reduced sales of $1B for an annual net profit of $300M. More likely in my mind to be a partnership and further funds injection from that type of transaction. 03/11/23. KZA. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. in a post an hour ago, is simply not correct. Latest Posts. ASX - Day TradingCreated with Sketch. 51pm 21/11/2023 ? HotCopper has news, discussion, prices and market data on ARCHER MATERIALS LIMITED. rights. which features studies in PI3K Pathway Inhibition (most agree that is what the KZA drug. ASX - Day TradingI believe we need a comprehensive shareholder briefing webinar and Q&A with management to address the accelerated non-renounceable entitlement offer as. 1212. Other Market Research Available. . 0¢ Sentiment: Hold Disclosure: Held. 1 Upvote. ASX - Day TradingApplication for quotation of securities - KZA. . 2. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. 0¢ Sentiment: Buy Disclosure: HeldKazia GDC-0084 SNO poster, page-3. In the event that a combination involving paxalisib does show promising efficacy, the Page 4 Kazia Therapeutics (KZA) 14 December 2020 registration pathway would be determined by the strength of the signal and safety profile. 52 would see the support line of the uptrend remain. KZA up nearly 300% (from 250% around a couple of weeks ago) NOX at near zero 0% MSB down approx 20% KTRA (NASDAQ) down approx 90% it’s obvious Paxalisib is seen to be the superior compound So it’s very clear that Paxalisib has great support from: - our management team - our science board - our independent trial partners It is very difficult to manage a company and at the same time increase the company's share value , with the utmost respect to KZA , I feel it is time for management to hand over the reigns to a new team , who can bring renewed enthusiasm to ways of improving value to KZA share holders . 52, $0. Created with Sketch. , page-4. ASX - By Stock. 81M. Created with Sketch. As mentioned before. Oct 11 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA ANNOUNCES INTENTION TO VOLUNTARILY DE-LIST FROM ASX SUBMITTED A FORMAL APPLICATION TO ASX TO BE. A reversal at $0. Created with Sketch. A reversal at $0. ASX - Day TradingThought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Advertise. Join the HotCopper ASX share market forum today for free. Regards. 75 yrs duration hopefully KZA will go the distance last reasonable length was 2010-2017 Helsinki Group JG is still the CEO of Kazia according to his LinkedIn profile - so he’s not been quick to update that at least. Kazia announces Clinical Data at ESMO 2023 from EVT801 StudyKAZIA THERAPEUTICS LIMITED (ASX:KZA) - Ann: Trading Halt, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By. 36 79993 Canadian Dollars. Latest Posts. ASX - By Stock. Latest Posts. Created with Sketch. The initial 7 children in 2020, would have been part of compassionate drug use- meaning a new, unapproved drug (or combo). 40. Up nearly 35% And not showing any signs Of slowing down. (like this, which is good. ASX - By Stock. Within the next few days the 2,391,865 shares issued on 30/4/21 at $1. ASX - By Stock. Created with Sketch. Good luck all. 0. . 0219 (-2. Advertise on HotCopper. Proposed issue of securities - KZA. . ASX - Day TradingKazia Share Purchase Plan raises $1. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. . ASX - Day Trading26th Annual Meeting and Education Day of the Society for Neuro-Oncology November 18 - 21, 2021. Currently unlisted public company. May 19, 2023 – 11. KZA shares jumped by another 35 per cent, two weeks after gaining more than 50 per cent when the company announced paxalisib had. Now thanks to the like of Dr Wen and other professionals not associated with the company who are happy to put their names and reputations on the line by speaking and publishing for Paxalisib. Latest Posts. Click for more information. Alot of what you just said bmfjch. 0¢ Sentiment: Hold Disclosure: Held. Potential exhaustion levels for the current pullback are $0. This constitutes a price movement of 3. I have roughly equal amounts invested in KZA and PAB. Can I suggest to you, like many - you have been caught up in. KZA. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Share I love paxalisib, evt801 has real potential. 00 Days 00 Hours 00 Minutes 00 Seconds 2023 National Workshops in. ASX - By Stock. . 1 CAD = 0. Created with Sketch. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. 80. ASX - By Stock. question is when. Just for some fun. ASX - Day TradingCompletion of recruitment to paxalisib P2 GBM studyKazia GDC-0084 SNO poster, page-5. .